ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,162Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 617

$737K Total Retail Price of All Prescriptions

Rank: 22 out of 617

457 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 457 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 457 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 11,880 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 582 544 1 1
AMLODIPINE BESYLATE 506 466 2 6
OMEPRAZOLE 491 451 3 3
LISINOPRIL 374 327 4 5
SIMVASTATIN 335 312 5 2
PRAVASTATIN SODIUM 334 316 6 21
WARFARIN SODIUM 323 294 7 7
FUROSEMIDE 300 274 8 4
METFORMIN HCL 282 243 9 9
CARVEDILOL 273 268 10 19
HYDROCODONE-ACETAMINOPHEN 262 230 S3 11 8
CITALOPRAM HBR 251 230 12 18
ATORVASTATIN CALCIUM 250 229 13 14
GABAPENTIN 234 187 14 16
CRESTOR 187 161 15 28
HYDROCHLOROTHIAZIDE 184 167 16 13
METOPROLOL SUCCINATE 178 140 17 12
METOPROLOL TARTRATE 160 149 18 11
LOSARTAN POTASSIUM 157 150 19 22
TRAMADOL HCL 155 114 20 15
TAMSULOSIN HCL 155 152 20 26
POTASSIUM CHLORIDE 145 131 22 10
DONEPEZIL HCL 142 138 23 30
ALENDRONATE SODIUM 123 111 24 25
VENLAFAXINE HCL ER 117 104 25 76
DIOVAN 116 107 26 41
SPIRIVA 112 107 27 61
MELOXICAM 109 79 28 24
NAMENDA 105 99 29 35
ALLOPURINOL 105 98 29 27
CYMBALTA 104 79 31 49
MIRTAZAPINE 99 88 32 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 98 32 29
BYSTOLIC 95 91 34 64
PREDNISONE 90 88 35 31
ATENOLOL 85 85 36 17
ROPINIROLE HCL 80 79 37 66
CLONIDINE HCL 77 77 38 55
LANTUS 76 76 39 39
ZETIA 73 73 40 77
ZOLPIDEM TARTRATE 72 57 41 23
AMLODIPINE BESYLATE-BENAZEPRIL 70 70 42 80
PANTOPRAZOLE SODIUM 69 69 43 37
RAMIPRIL 69 50 43 67
PLAVIX 68 68 45 86
PEN NEEDLE 64 59 46 174
CLOPIDOGREL 63 63 47 53
SYNTHROID 62 56 48 59
SERTRALINE HCL 62 45 48 20
FAMOTIDINE 60 60 50 54
POLYETHYLENE GLYCOL 3350 58 48 51 32
BENAZEPRIL HCL 58 45 51 44
VESICARE 57 45 53 95
CARBIDOPA-LEVODOPA 56 56 54 69
TRAZODONE HCL 55 48 55 51
LANTUS SOLOSTAR 54 53 56 115
RANITIDINE HCL 54 52 56 40
NEXIUM 54 50 56 43
TRANDOLAPRIL 53 53 59 236
CEPHALEXIN 52 47 60 68
LIPITOR 51 36 61 118
LEVOFLOXACIN 51 48 61 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.